HOOK
insider transactionsHOOKIPA Pharma Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-68.0K
0 buy · 68.0K sell
Net value · 365d
-$60.0K
$0 in · $60.0K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 68.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Peters Malte KEY
Chief Executive Officer
$20.6K
25.2K sh · $0.82
Own -32%
-
Sell·S
EVP and CFO
$12.5K
13.6K sh · $0.92
Own -19%
-
Sell·S
Peters Malte KEY
Chief Executive Officer
$26.8K
29.2K sh · $0.92
Own -27%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2025 | Peters Malte KEY | Sell S | 25.2K | $20.6K |
| Jul 22, 2025 | Coelho Mary Theresa KEY | Sell S | 13.6K | $12.5K |
| Jul 22, 2025 | Peters Malte KEY | Sell S | 29.2K | $26.8K |
About HOOK insider trading
This page tracks insider transactions for HOOKIPA Pharma Inc. (HOOK) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.